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Abstract
Background: This biomechanical study evaluates the effect of N-acetylcysteine alone and in combination with the
most commonly used antibiotic-loaded bone cement mixtures.
Methods: We mixed eight bone cement mixture groups including combinations of N-acetylcysteine, gentamicin,
teicoplanin, and vancomycin and applied a four-point bending test individually to each sample on days 1 and 15
using an MTS Acumen test device.
Results: The result was less than 50 MPa—the limit declared by the ISO (International Standards Organization)—in
only the “gentamicin + bone cement + N-acetylcysteine” group. Mechanical fatigue resistance of the bone cement
decreased significantly with the addition of N-acetylcysteine both on day 1 and day 15 (p < 0.001). With the addition
of N-acetylcysteine into the “gentamicin + bone cement” and “vancomycin + bone cement” mixtures, a significant
decrease in mechanical fatigue resistance was observed both on day 1 and day 15 (p < 0.001). In contrast, with the
addition of N-acetylcysteine into the “teicoplanin + bone cement” mixture, no significant difference in mechanical
fatigue resistance was observed on days 1 and 15 (p = 0.093, p = 0.356).
Conclusion: Preliminary results indicate that adding N-acetylcysteine to teicoplanin-loaded bone cement does not
significantly affect the cement’s mechanical resistance, potentially leading to a new avenue for preventing and treating
peri-prosthetic joint infection. N-acetylcysteine may, therefore, be considered as an alternative agent to be added to
antibiotic-loaded bone cement mixtures used in the prevention of peri-prosthetic joint infection.
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Background
Peri-prosthetic joint infection (PJI) is one of the most
feared and devastating complications following total
joint arthroplasty (TJA). PJI treatment through antibi-
otics is complex and challenging on account of biofilm
formation, which tends to protect pathogens from the
effects of systemic antibiotics as well as host immune
system [1].
Antibiotic-loaded bone cement (ALBC) prophylaxis
promises to be an effective strategy towards reducing
the risk of infection following TJA [2] and is commonly
used for high-dose local delivery of antibiotics to the
surgical site to inhibit biofilm formation and thereby
avoiding the occurrence of systemic side effects caused
by an over-dosage of antibiotics [1, 3]. For the prophy-
lactic use of ALBC, the antibiotic should not be used at
high doses because increasing quantities of antibiotic
powder may reduce the compressive and tensile
strengths of bone cement [1]. As a result, the amount of
antibiotic that can be added to bone cement is limited,
thereby limiting their effectiveness against certain
micro-organisms. Moreover, adding antibiotics to ALBC
may theoretically contribute to an increased resistance
towards antibiotics; as a consequence, the probability of
obtaining a negative culture result in subsequent aspira-
tions also increases [3, 4].
N-acetylcysteine (NAC) is a non-antibiotic drug and
antioxidant amino acid that is generally safe and
* Correspondence: erhan_sukur@hotmail.com
1Department of Orthopedics and Traumatology, Sakarya University Research
and Training Hospital, 54050 Sakarya, Turkey
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sukur et al. Journal of Orthopaedic Surgery and Research  (2018) 13:132 
https://doi.org/10.1186/s13018-018-0843-9
well-tolerated, even at high doses; further, it has a highly
favorable risk/benefit ratio and a low rate of adverse
events [5, 6]. Studies have shown that NAC reduces bio-
film formation, inhibits bacterial adherence, and
decreases the production of extracellular polysaccharide
matrix and cell viability [7–10]. Since NAC exhibits a
synergistic antibacterial and anti-biofilm activity, the
proposed study has been designed to evaluate its effects
on the mechanical properties of bone cement when used
exclusively as well as in combination with commonly
used antibiotic mixtures, such as gentamicin, teicopla-
nin, and vancomycin. It has been hypothesized that its
addition would cast a curtailing effect on the biomech-
anical properties of bone cement, and its combination
with antibiotics causes further aggravation of this effect.
Methods
Cement mixture preparation
Eight bone cement mixture groups were prepared con-
taining various combinations of bone cement, NAC
along with varying concentrations of gentamicin, teico-
planin, and vancomycin, as described in Table 1. Each
group was prepared by mixing the ingredients together
for 45 s using commercially available mechanical mixing
bowls under a constant vacuum pressure of approxi-
mately 200 mbar in a controlled environment with
temperature and relative humidity values corresponding
to 22 ± 1 °C and 40–60%, respectively [11].
Sample preparation
Special rectangular-prism-shaped molds measuring 3.3 ×
10 × 75 mm, as shown in Fig. 1a, b), were prepared in ac-
cordance with the size recommended by the International
Standards Organization (ISO 5833). Upon attainment of
dough-like viscosity values, the prepared mixtures were
made to fill the prism-shaped molds by pouring them into
the molds simultaneously by hand and applying pressure
to completely occupy all molds and gaps. Subsequently,
the molds were pressed between two metal plates through
use of a clamp and maintained between the plates for
15 min to facilitate cement-mixture hardening. Burrs, cre-
ated during removal of mixture samples from the molds
using a special remover, were subsequently cleaned. The
samples were then macroscopically examined for manu-
facturing defects (as depicted in Fig. 1c, d). Defected sam-
ples, wherein more than 10% of the section surface
exhibited signs of defects, were discarded from the study.
Twenty samples were prepared from each group, 10 of
which were evaluated on day 1 while the remaining were
evaluated on day 15. Samples scheduled for evaluation on
day 15 were set apart for 15 days to be maintained in a
37 °C normal saline bath, wherein antibiotics were
released from the surface of the sample. In order to pre-
vent saturation of the environment due to antibiotic
release and facilitate maximum antibiotic secretion, the
saline solution containing the samples was changed on a
daily basis.
Biomechanical testing
Acumen (MTS Systems Corporation, MN, USA) electro-
dynamic testing device was used for biomechanical
evaluation of the prepared samples. A four-point bend-
ing test was independently performed on 10 samples
each on day 1 and day 15. During the test, a certain
bending force was exerted upon the samples at a speed
of 3 mm/min, and corresponding uniaxial bending stress
values were calculated in MPa (N/mm2). The value of
the bending stress recorded at the instant at which the
sample failed was considered as the mechanical fatigue
resistance limit (Fig. 2a, b).
Statistical analysis
Statistical evaluation in the proposed study was performed
using the SPSS 22.0 application for Windows (SPSS Inc.,
Chicago, IL, USA). Descriptive statistics were provided to
represent the mean and standard deviation for numeric
variables. Student’s t test was performed when numeric
variables were normally distributed, and multiple groups
were compared using the one-way ANOVA test. Add-
itionally, the Mann–Whitney U test and the Kruskal–
Wallis test were performed when numeric variables did
not exhibit normal distribution. For a parametric
sub-group analysis comprising more than two groups, the
Tukey test was performed. For non-parametric analyses,
on the other hand, the Mann–Whitney U test with Bon-
ferroni correction was preferred. The significance level for
each of the above tests was set at 0.05.
Results
Results of the biomechanical evaluation described
above are summarized and presented in Table 2. As
seen in Table 2, only samples belonging to group 4
Table 1 Cement mixture groups
Group Cement mixture ingredients
1 Bone cementa
2 Bone cement + 600 mg NACb
3 Bone cement + 0.5 g gentamicinc
4 Bone cement + 0.5 gentamicin + 600 mg NAC
5 Bone cement + 1 g vancomycind
6 Bone cement + 1 g vancomycin + 600 mg NAC
7 Bone cement + 400 mg teicoplanine
8 Bone cement + 400 mg teicoplanin + 600 mg NAC
aVersabond cement (40 g polymer powder + 20 mL monomer liquid)
bAcetyl-L-cysteine (Sigma Aldrich, A7250)
cCemex Genta
dEdicin 1 g (Sandoz, Serbia)
eTargocid, Sanofi Aventis, Italy
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demonstrated a value of the failure bending stress less
than 50 MPa (the limiting value declared by ISO).
The mechanical fatigue resistance (MFR) of bone
cement samples was found to have significantly
decreased upon addition of NAC. This result was
consistent in the biomechanical testing of samples
performed on day 1 as well as day 15 (p < 0.001). As
depicted in Fig. 3a, NAC addition to the group 3
mixture causes a significant decrease in MFR (p
< 0.001), as observed on day 1 as well as day 15. In
the case of NAC addition to the group 5 mixture, a
significant difference was observed between MFR
values recorded on day 1 and day 15 (p < 0.001), as
depicted in Fig. 3b. NAC addition to the group 7
mixture, however, demonstrated no significant differ-
ence between MFR values recorded on day 1 and day
15 (p = 0.093 and p = 0.356, respectively), as depicted
in Fig. 3c.
Discussion
Although some in vitro studies have evaluated the anti-
biofilm and antimicrobial effects of NAC in bone
cement, to our knowledge, this is the first study to
evaluate the biomechanical features of NAC and ALBC
applied together. We observed that adding NAC to
teicoplanin-loaded bone cement did not affect its MFR
on day 1 or day 15. On the other hand, adding NAC into
gentamicin- and vancomycin-loaded bone cement de-
creased biomechanical features of the bone cement.
Biofilm formation is a bacterial behavior that impedes
the effectiveness of PJI therapy [5], and inadequate
ALBC application may lead to the proliferation of resist-
ant bacteria strains and cannot obviate biofilm formation
[12]. In our study, we have chosen to evaluate a combin-
ation of ALBC and NAC, because NAC is a new
pharmacological approach to inhibiting biofilm forma-
tion, eradicating mature biofilms and increasing the
Fig. 1 a–d Rectangular-prism-shaped molds
Fig. 2 a, b Demonstration of four-point bending test
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permeability of antibiotics to overcome antibiotic resist-
ance [5]. We expected that adding NAC into ALBC may
worsen its mechanical properties by increasing the total
number of particles added to the cement. Although
compression tests are commonly performed to evaluate
the biomechanical resistance of bone cement, we per-
formed four-point bending tests as described by ISO,
because they are more sensitive to surface defects and
internal porosity [13, 14].
ALBC is used to avoid systemic toxicity from antibi-
otics and maximize their local concentration, inhibiting
biofilm formation at the infection site in the treatment
and prophylaxis of PJI [15–17]. Currently, antibiotic
doses in ALBC vary depending on the application. When
ALBC is used to treat an existing infection, appropriate
therapeutic levels can be achieved by loading more than
2 g of antibiotics into 40 g of bone cement [1]. However,
the addition of antibiotics into bone cement decreases
its compressive and tensile strength. Furthermore, this
decrease is augmented by increasing the antibiotic dose
[18]. Hence, a maximum of 1–2 g of antibiotics can be
loaded into 40 g of bone cement for infection prophy-
laxis [1, 18, 19].
In the current study, the cement mixtures were
formed by adding prophylactic doses of three types of
antibiotics (0.5 g gentamicin, 1 g vancomycin, and
400 mg teicoplanin) and 600 mg NAC into bone cement
to mimic prophylactic application. Consistent with the
literature, we observed a significant decrease in mechan-
ical properties with the addition of antibiotics alone into
the bone cement in a four-point bending test [1, 18].
Similarly, adding only NAC negatively affected the bone
cement’s mechanical properties. However, we found no
available literature on the effect of NAC addition into
bone cement on its biomechanical properties. Thus, it
was not possible to compare our results. We postulate
that adding NAC to bone cement decreased its mechan-
ical properties by increasing the number of particles in
the cement.
A homogenous mixing and pressurization during
implantation are crucial for better mechanical properties
of the bone cement. The use of vacuum-mixing of the
cement causes less porosity and less reduction of the
tensile fatigue strength of ALBC than hand-mixing [1].
In a current study, it was concluded that the standard
method using a plastic pressurizer with cement gun after
vacuum mixing appears to be adequate for achievement
of optimum pressurization during femoral cementing
without increased risk of embolization [19]. In our study,
we used the vacuum mixing method to optimize the
cement porosity.
Our results showed that 600 mg of NAC may be safely
added to bone cement while maintaining sufficient bio-
mechanical resistance against bending and shearing
Table 2 Results of the biomechanical tests
Peak load N (day 1) Peak load N (day 15)
Mean ± SD Mean ± SD p
Group 1 107.7 ± 3.5 100.4 ± 4.1 0.001
Group 2 93.3 ± 3.4 87.3 ± 4.6 0.017
p < 0.001 < 0.001
Group 3 91.2 ± 3.5 86.8 ± 5.1 0.005
Group 4 77.3 ± 6.3 49.2 ± 4.2 < 0.001
p < 0.001 < 0.001
Group 5 93.2 ± 6.1 87.6 ± 3.2 0.077
Group 6 76.3 ± 7.6 62.4 ± 3.3 0.002
p < 0.001 < 0.001
Group 7 93.2 ± 4.3 83.9 ± 4.0 < 0.001
Group 8 88.5 ± 2.8 81.9 ± 4.4 0.001
p 0.093 0.356
Fig. 3 a–c The comparison of the results
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forces. However, in this study, adding NAC to
gentamicin-loaded bone cement significantly decreased the
mechanical strength of the mixture, consistent with our hy-
pothesis. Our four-point bending test result was less than
the minimum ISO requirement of 50 MPa in the 0.5 genta-
micin + 600 mg NAC+ bone cement group. Similarly,
Lautenschlager et al. observed decreased mechanical resist-
ance in gentamicin-loaded bone cement [20]. In our study,
adding NAC to vancomycin-loaded bone cement signifi-
cantly decreased its biomechanical resistance; however, this
mixture achieved bending test results of at least 50 MPa on
both days 1 and 15. By contrast, adding NAC to 400 mg
teicoplanin-loaded bone cement did not adversely affect its
mechanical properties. Gogus et al. investigated the effects
of increasing doses of teicoplanin in bone cement on the
cement’s biomechanical properties and found that doses
greater than 2000 mg added into bone cement (40 g poly-
mer powder + 20 mL monomer liquid) decreased its mech-
anical resistance past the critical lower limit. In addition to
the concentration and type of antibiotics, the brand of the
antibiotic and the bone cement also affects biomechanical
properties [20–22], which might cause the variability of the
results in the available literature.
The main limitation of our study was that the antibi-
otics were added to the bone cement only in prophylac-
tic doses, and the effect of only a single dose of NAC
was evaluated. Determining the correct dose of NAC for
use in combination with optimized antibiotic doses in
bone cement requires further study. Additionally, only a
four-point bending test was performed; compressive
resistance limits were not evaluated in our study.
Conclusions
This study examines the mechanical properties of
antibiotic-loaded bone cement after the addition of N-acet-
ylcysteine. We have shown preliminary results indicating
that adding N-acetylcysteine to teicoplanin-loaded bone ce-
ment does not significantly affect the cement’s mechanical
resistance, potentially leading to a new avenue for prevent-
ing and treating PJI. However, this effect varies with the
type and amount of antibiotic used in the mixtures. Bone
cement mixtures containing a combination of NAC and an-
tibiotics may be manufactured and used clinically.
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